Zuellig Pharma Acquires Leading Brands from Bayer AG
Zuellig Pharma has announced the acquisition of household names Zam-Buk® and Vapex® from Bayer AG, representing a significant growth milestone in its consumer healthcare portfolio.
By
APAC Insights on Healthcare Outlook spotlights visionary leaders advancing healthcare across the APAC region, delivering expert perspectives and innovative approaches transforming the industry.
Zuellig Pharma has announced the acquisition of household names Zam-Buk® and Vapex® from Bayer AG, representing a significant growth milestone in its consumer healthcare portfolio.
